Impact of Plant-Based Diets During Pregnancy on Health Outcomes
VEGALIM : Vegetalization of the Maternal Diet During Pregnancy: Association With Pregnancy Outcomes and Newborn Health.
This study is looking at how eating a plant-based diet during pregnancy affects the health of mothers and their babies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 670 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 1 site (Nantes, Loire-Atlantique) |
| Trial ID | NCT06155344 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the effects of a plant-based diet on pregnant women's health and the health of their newborns. It focuses on assessing the level of vegetalization in the diets of pregnant women during their first trimester and late pregnancy. The study will utilize food frequency questionnaires and collect maternal blood samples to analyze plasma lipid profiles. The goal is to understand how these dietary patterns may influence maternal and newborn health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women consulting at the Nantes University Hospital for pregnancy monitoring, specifically between 11 and 13 weeks of gestation.
Not a fit: Patients under 18 years of age or those with cognitive impairments that prevent them from completing questionnaires may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how plant-based diets during pregnancy may improve health outcomes for mothers and their newborns.
How similar studies have performed: While there is limited data on the effects of maternal plant-based diets specifically, existing studies on adult populations suggest potential health benefits, indicating this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria : * Pregnant women consulting the CEMAFOER at the Nantes University Hospital for pregnancy monitoring * Gestational age between 11 and 13 AW +6 days * Understanding French Exclusion Criteria: * Patients under 18 years of age * Patient who objected to being included in the study * Patient with cognitive problems that prevent her from answering questionnaires
Where this trial is running
Nantes, Loire-Atlantique
- CHU de Nantes — Nantes, Loire-Atlantique, France (Recruiting)
Study contacts
- Principal investigator: Norbert Winer, MD, PHD — Nantes University Hospital
- Study coordinator: Norbert Winer, MD, PHD
- Email: norbert.winer@chu-nantes.fr
- Phone: +33 (0)2 40 08 78 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.